DSpace Repository

Pharmaceutical Cocrystals—A Review †

Show simple item record

dc.contributor.author Buddhadev, Sheetal
dc.contributor.author Garala, Kevin
dc.date.accessioned 2023-05-27T02:49:32Z
dc.date.available 2023-05-27T02:49:32Z
dc.date.issued 2020-11
dc.identifier.citation Buddhadev, S. ,Garala, K. ,Pharmaceutical Cocrystals—A Review †. Proceedings Journals (MDPI), Proceedings 2020, 62, 14; doi:10.3390/proceedings2020062014 en_US
dc.identifier.issn 2504-3900
dc.identifier.uri http://10.9.150.37:8080/dspace//handle/atmiyauni/1121
dc.description Writer is grateful to Noble Pharmacy College and Atmiya Institute of Pharmacy for their continuous support. en_US
dc.description.abstract The design and synthesis of pharmaceutical cocrystals have received great interest in the recent years. Cocrystallization of drug substances offers a tremendous opportunity for the development of new drug products with superior physical and pharmacological properties such as solubility, stability, hydroscopicity, dissolution rates and bioavailability. This short review summarizes this highly topical field, covering why the topic is of interest in pharmaceutical formulation, the definitions and practical scope of cocrystals, cocrystal preparation and characterization, a comparison of different (traditional and novel) methods for cocrystal formation and the implications for regulatory control and intellectual property protection. Traditionally, cocrystals can be prepared by solvent evaporation method, grinding, and slurry method, but every method has its limitations for certain conditions. The current trend for cocrystal formation uses sophisticated methods such as the hot melt extrusion method, spray-drying method, supercritical fluid technology and the newest method: laser irradiation. The purpose of the development of a new method is not only to overcome the limitation of traditional cocrystallization methods, but also to generate simpler steps and a continuous process for the production of the cocrystal product. This article provides a brief explanation of each method that can be used to generate pharmaceutical cocrystals as well as evaluation of cocrystals. This article also covers how the developing field of cocrystallization may impact the pharmaceutical intellectual property landscape. en_US
dc.language.iso en en_US
dc.publisher Proceedings Journals (MDPI) en_US
dc.subject pharmaceutical cocrystals (PC) en_US
dc.subject cocrystallization en_US
dc.subject active pharmaceutical ingredient (API) en_US
dc.subject generally recognized as safe (GRAS) en_US
dc.subject cocrystal former (CF) en_US
dc.subject novel methods en_US
dc.subject traditional methods en_US
dc.title Pharmaceutical Cocrystals—A Review † en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account